Teahose.
SIGN IN
NEW HERE — WHAT TEAHOSE DOES
We read the entire AI & tech firehose — so you don't have to.
PODPodcastsAll-In, No Priors, Acquired…
NEWNewslettersStratechery, Newcomer…
PAPPapersPhysical AI research
PHProduct Huntdaily launches
VCInvestor ScoutSequoia, a16z, Benchmark…
CLAUDE DISTILLS →
7 reads, 30 sec each — free, 6 AM ET.
+ a live graph of the companies, people & themes underneath.
HOME/PEOPLE/MAX HODAK
// PERSON

Max Hodak

ROLE FOUNDER AND CEOMENTIONS 10LAST SEEN AUGUST 20, 2026
// BIO

Max Hodak is an American entrepreneur and biomedical engineer who is the founder and CEO of Science Corporation, a company developing neural technologies aimed at restoring vision and cognition. He co-founded Neuralink with Elon Musk in 2016 and served as its president until early 2021, when he left to establish Science Corporation. Science Corporation's PRIMA retinal implant, paired with camera-equipped glasses, has completed pivotal clinical trials showing significant vision improvements in patients with age-related macular degeneration. Prior to Neuralink, he founded Transcriptic, a robotic cloud laboratory for life sciences, in 2012 after graduating from Duke University with a degree in biomedical engineering.

Discussed in
// RECENT MENTIONS
// SIGNALS
10 SIGNALS
01
mention·No Priors·AUGUST 20, 2026

“There's this 10 bit per second kind of famous cognitive bottleneck... There's like a bunch of different independent lines of evidence for this. So there's some deeply evolved cognitive bottleneck at about that. And I think that this kind of rolls up through language.”

Source→
02
m_and_a·No Priors·AUGUST 20, 2026

“There was a company in France called Pixium that back in late 2022 had by far the state-of-the-art work... we're in a position to acquire them when we saw something that I think kind of nobody else really saw at the time.”

Source→
03
product·No Priors·AUGUST 20, 2026

“Prima has received CE mark approval in Europe and will begin commercial sales within weeks of the podcast recording.”

Source→
04
funding·No Priors·AUGUST 20, 2026

“There's only one VC that I sought out at all at the Series A that I went to go pitch, which was Bob Nelson, who's a biotech investor.”

Source→
05
mention·No Priors·AUGUST 20, 2026

“The brain very literally, very clearly, plainly is a computer... If I put electrodes in M1, you will probably be using a computer in an hour.”

Source→
06
product·Lightcone·AUGUST 10, 2026

“Our main product is a retinal prosthesis. It's a chip that's implanted under the retina in the back of the eye to restore vision to patients that have gone blind due to loss of the rods and cones in their eye.”

Source→
07
mention·Lightcone·AUGUST 10, 2026

“If you can learn one thing every week, and there's a competitor that's learning a thing every month, they will never matter.”

Source→
08
mention·Lightcone·AUGUST 10, 2026

“There are definitely some ideas that are worth funding with $50 million or $0, but not $5 million. You won't run the experiment. It'll be a really frustrating experience. You'll get an ambiguous outcome... figure out what it costs to actually run the experiment. Raise twice that.”

Source→
09
hire·Lightcone·AUGUST 10, 2026

“I spent five years running a company for my CEO at Neuralink. I was working with someone who has empirically excellent judgment.”

Source→
10
product·StrictlyVC·JULY 23, 2026

“Won European approval to sell PRIMA, an implantable retinal chip paired with camera-equipped glasses that restores functional vision for patients with age-related macular degeneration.”

Source→

AI-extracted from podcast / newsletter / paper summaries. May contain errors.